Mayo Clinic Comprehensive Cancer Center mission and vision

    Our mission is to ensure that all patients receive the finest cancer care in the nation, derived from outstanding research, constant innovation, compassion, and sharing of our data, knowledge and expertise. To achieve health equity, we deeply engage and support the patients and communities we serve.

    With the support of our patients, benefactors and government agencies, we seek to become the cancer center of the future — a global cancer authority — from interception through diagnosis and treatment to survivorship. We envision a center without walls, based on all Mayo Clinic strengths, to deliver cancer expertise to people and communities no matter where they are.


    Achieving our vision

    To become a cancer center without walls that delivers better cancer expertise to everyone, everywhere, we've set six strategic goals that drive our decisions.

    1. Deepened cancer discovery science
      Drive and deepen innovative discovery and translational science.
    2. Early cancer detection and interception
      Drive innovative science and practice to transform the way we detect and intercept cancer at its earliest stages and prevent progression to more-advanced disease.
    3. Novel cancer therapeutics and therapeutic modalities
      Discover, develop and deliver innovative therapies and novel treatment modalities to prevent and treat cancer, particularly advanced and complex cancers.
    4. Data science, predictive modeling and AI
      Connect patients and communities with data to create new knowledge that will transform cancer care, and drive research to prevent and better treat cancer, thereby improving outcomes for all.
    5. Transformed cancer care delivery
      Through platform transformation, create the optimal patient-centric cancer care delivery model and digital front door, blending virtual, in-facility, and Cancer Care Beyond Walls, to optimize patient access and experience.
    6. Transformed and decentralized clinical trials
      Fully transform access, diverse participation and delivery of decentralized cancer clinical trials, bringing trials to people and communities across geographic boundaries using digital and platform innovation, thereby achieving health equity.

    Mayo Clinic Comprehensive Cancer Center leadership

    Cheryl Willman

    Cheryl L. Willman, M.D.

    Stephen and Barbara Slaggie Executive Director, Mayo Clinic Cancer Programs, and Director, Mayo Clinic Comprehensive Cancer Center
    Site Director, Rochester/Midwest

    Jolene Bolster

    Jolene M. Summer Bolster

    Enterprise Executive Administrator
    Deputy Director, Administration

    Tina R. Devery
    Associate Director, Administration

    Stephen M. Ansell, M.D., Ph.D.
    Enterprise Deputy Director
    Site Deputy Director, Rochester/Midwest

    Rick J. Bold, M.D.
    Site Deputy Director, Arizona

    Roxana S. Dronca, M.D.
    Site Deputy Director, Florida

    William Sanchez, M.D.
    Robert R. McWilliams, M.D.
    Judy C. Boughey, M.D.
    Nadia N. Laack, M.D.
    Linda M. McAllister, M.D., Ph.D.

    Deputy Directors, Research and Practice Integration, Practice Transformation

    Sarah A. McLaughlin, M.D.
    Deputy Director, Disease Groups

    Grzegorz S. Nowakowski, M.D.
    Deputy Director, Clinical Research

    Matthew P. Goetz, M.D.
    Deputy Director, Translational Research

    Daniel D. Billadeau, Ph.D.
    Deputy Director, Basic Research

    James R. Cerhan, M.D., Ph.D.
    Deputy Director, Population Science

    Folakemi T. Odedina, Ph.D.
    Deputy Director, Community Outreach and Engagement (COE)

    Bruce F. Horazdovsky, Ph.D.
    Deputy Director, Cancer Research Training and Education Coordination (CRTEC)

    Felicity T. Enders, Ph.D.
    Deputy Director, Diversity, Equity, Inclusion and Accessibility (DEIA)

    Institutional platforms and resources

    Aadel A. Chaudhuri, M.D., Ph.D.
    Mrinal S. Patnaik, M.B.B.S.
    Jewel J. Samadder, M.D.
    Cancer Individualized Precision Medicine

    Tufia C. Haddad, M.D.
    John D. Halamka, M.D.

    Platform and Digital Innovation

    Karla V. Ballman, Ph.D.
    Eric W. Klee, Ph.D.
    Irbaz B. Riaz, M.B.B.S.

    Cancer Informatics, Data Science, AI

    William A. Faubion, M.D., Ph.D.
    Yi Lin, M.D., Ph.D.

    Center for Regenerative Biotherapeutics

    Sikander Ailawadhi, M.D.
    International Cancer Programs


    Your gift holds great power – donate today!

    Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.